Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Regeneron (NASDAQ: REGN) | Delayed: 802.05 -17.04 (2.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $819.09 | 52 Week High | $592.36 | |||
| Open | $819.09 | 52 Week Low | $325.35 | |||
| Day High | $819.09 | P/E | 210.51 | |||
| Day Low | $802.05 | EPS | $3.81 | |||
| Volume | 71,771 | |||||
